Evidence map›Paper›PMID 42192993›Full record

ReviewCancers2026

Evaluation of Efficacy and Safety of Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cells in Breast Cancer: A Systematic Review and Meta-Analysis.

Nabeel Ahmed, Jawaria Jabeen, Safa Noor, Malja Rehman, Sana Tahseen, Asmaa Qamar, Muhammad Anas, Muhammad Muneeb Khalid, Tao Li, Lechun Lyu and 1 more

Abstract readReview
In one paragraph

Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nabeel AhmedYunnan Key Laboratory of Plateau Thermal Medical Rehabilitation and Wellness, School of Rehabilitation, Kunming Medical University, Kunming 650500, China.ORCID 0009-0009-7550-213X
Jawaria JabeenCollege of Pharmacy, University of Sargodha, Sargodha 40100, Pakistan.
Safa NoorCollege of Pharmacy, University of Sargodha, Sargodha 40100, Pakistan.
Malja RehmanCollege of Pharmacy, University of Sargodha, Sargodha 40100, Pakistan.ORCID 0009-0001-0524-1941
Sana TahseenPunjab University College of Pharmacy, University of the Punjab, Lahore 54000, Pakistan.
Asmaa QamarCollege of Pharmacy, University of Sargodha, Sargodha 40100, Pakistan.
Muhammad AnasCollege of Pharmacy, University of Sargodha, Sargodha 40100, Pakistan.
Muhammad Muneeb KhalidCollege of Pharmacy, University of Sargodha, Sargodha 40100, Pakistan.
Tao LiCancer Biotherapy Center & Cancer Research Institute, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming 650106, China.
Lechun LyuYunnan Key Laboratory of Plateau Thermal Medical Rehabilitation and Wellness, School of Rehabilitation, Kunming Medical University, Kunming 650500, China.
Zhiwei HuPelotonia Institute for Immuno-Oncology Center for Antibody Therapeutics, The Arthur G. James Comprehensive Cancer Center, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.ORCID 0000-0002-0023-1170

Funding

Pelotonia Idea Awards IRP00915The Ohio State University Comprehensive Cancer Center Intramural Research Program IRP01207
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adoptive cell therapybreast cancerCAR-NKimmunotherapymeta-analysisnatural killer cells

Identifiers

PMID42192993
PMCPMC13204228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.